These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 27086670)
1. New Treatment for Percutaneous Sites in Patients with a Ventricular Assist Device: Nihon University Crystal Violet Method. Sezai A; Niino T; Osaka S; Yaoita H; Arimoto M; Hata H; Shiono M Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):246-50. PubMed ID: 27086670 [TBL] [Abstract][Full Text] [Related]
2. New Treatment for Infection of the NIPRO LVAD Cannula Site: Nihon University Crystal Violet Method. Sezai A; Niino T; Osaka S; Yaoita H; Arimoto M; Hata H; Shiono M Ann Thorac Surg; 2016 Jan; 101(1):348-50. PubMed ID: 26694275 [TBL] [Abstract][Full Text] [Related]
3. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation. Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225 [TBL] [Abstract][Full Text] [Related]
4. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices. Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303 [TBL] [Abstract][Full Text] [Related]
5. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation. Bhatia N; Voelkel AJ; Hussain Z; Sharma UC; Slaughter MS; Birks EJ; McCants KC Thorac Cardiovasc Surg; 2015 Dec; 63(8):675-83. PubMed ID: 26366889 [TBL] [Abstract][Full Text] [Related]
6. Driveline insulation as a conduit for left ventricular assist device pocket infection. Pinninti M; Thohan V; Sulemanjee NZ J Thorac Cardiovasc Surg; 2014 Jul; 148(1):e135-6. PubMed ID: 24755334 [No Abstract] [Full Text] [Related]
7. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary. Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262 [TBL] [Abstract][Full Text] [Related]
8. Late driveline left ventricular assist device infection treated with frozen-and-thawed allogeneic platelet gel. Formica F; Perseghin P; Cirò A; Paolini G Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):523-5. PubMed ID: 24920760 [TBL] [Abstract][Full Text] [Related]
9. A simple device to secure ventricular assist device driveline and prevent exit-site infection. Baronetto A; Centofanti P; Attisani M; Ricci D; Mussa B; Devotini R; Simonato E; Rinaldi M Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):415-7. PubMed ID: 24431003 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support. Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481 [TBL] [Abstract][Full Text] [Related]
11. Ventricular assist device application as a bridge to pediatric heart transplantation: a single center's experience. Hsu KH; Huang SC; Chou NH; Chi NH; Tsao CI; Ko WJ; Chen YS; Chang CI; Chiu IS; Wang SS Transplant Proc; 2012 May; 44(4):883-5. PubMed ID: 22564574 [TBL] [Abstract][Full Text] [Related]
13. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences. Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967 [TBL] [Abstract][Full Text] [Related]
14. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011. Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245 [TBL] [Abstract][Full Text] [Related]
15. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. Anand J; Singh SK; Hernández R; Parnis SM; Civitello AB; Cohn WE; Mallidi HR J Thorac Cardiovasc Surg; 2015 Jan; 149(1):267-75, 278.e1. PubMed ID: 25312232 [TBL] [Abstract][Full Text] [Related]
16. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy. Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985 [TBL] [Abstract][Full Text] [Related]
17. Prevention and early treatment of driveline infections in ventricular assist device patients - The DESTINE staging proposal and the first standard of care protocol. Bernhardt AM; Schlöglhofer T; Lauenroth V; Mueller F; Mueller M; Schoede A; Klopsch C; J Crit Care; 2020 Apr; 56():106-112. PubMed ID: 31896443 [TBL] [Abstract][Full Text] [Related]